Publications by authors named "Mirjam Epping"

Claim this Profile
P
Pre-hospital evaluation of chest pain patients using the modified HEART-score: rationale and design.
Jaouad Azzahhafi, Dean Rpp Chan Pin Yin, Mirjam Epping, Hajar Bofarid, Sem Aof Rikken

Future Cardiol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Andrea Lunardi, Ugo Ala, Mirjam T Epping, Leonardo Salmena, John G Clohessy

Nat Genet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulnerabilities of PTEN-TP53-deficient prostate cancers to compound PARP-PI3K inhibition.
Enrique González-Billalabeitia, Nina Seitzer, Su Jung Song, Min Sup Song, Akash Patnaik, Mirjam T Epping

Cancer Discov· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer.
Andrea Lunardi, Ugo Ala, Mirjam T Epping, Leonardo Salmena, John G Clohessy

Nat Genet· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.
Reinhard Dummer, Marc Beyer, Kenneth Hymes, Mirjam T Epping, Rene Bernards

Leuk Lymphoma· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TSPYL5 suppresses p53 levels and function by physical interaction with USP7.
Mirjam T Epping, Lars A T Meijer, Oscar Krijgsman, Johannes L Bos, Pier Paolo Pandolfi

Nat Cell Biol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.
Mirjam T Epping, Lars A T Meijer, Johannes L Bos, René Bernards

Mol Cancer Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The preferentially expressed antigen in melanoma (PRAME) inhibits myeloid differentiation in normal hematopoietic and leukemic progenitor cells.
Vivian G Oehler, Katherine A Guthrie, Carrie L Cummings, Kathleen Sabo, Brent L Wood, Mirjam T Epping

Blood· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.
Sidong Huang, Jamila Laoukili, Mirjam T Epping, Jan Koster, Michael Hölzel

Cancer Cell· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.
Mirjam T Epping, René Bernards

Int J Biochem Cell Biol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis.
Susan Fotheringham, Mirjam T Epping, Lindsay Stimson, Omar Khan, Victoria Wood

Cancer Cell· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors.
Mirjam T Epping, Liming Wang, Jane A Plumb, Michele Lieb, Hinrich Gronemeyer

Proc Natl Acad Sci U S A· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer.
Mirjam T Epping, René Bernards

Cancer Res· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.
Mirjam T Epping, Liming Wang, Michael J Edel, Leone Carlée, Maria Hernandez

Cell· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A transcriptional response to Wnt protein in human embryonic carcinoma cells.
Jennifer Willert, Mirjam Epping, Jonathan R Pollack, Patrick O Brown, Roel Nusse

BMC Dev Biol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptosis: target of cancer therapy.
Carlos G Ferreira, Mirjam Epping, Frank A E Kruyt, Giuseppe Giaccone

Clin Cancer Res· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis